J&J Bows Out of Race for Pfizer's $20B Consumer Health Biz Post author:Sam Post published:January 25, 2018 Post category:BioPharma Now insiders say J&J has decided it is no longer interested. Source: BioSpace You Might Also Like Former and FORUM Pharma CEO Resurfaces to Helm Massachusetts Biotech March 7, 2017 SI-BONE Announces Published Guidance Recommendation For Minimally Invasive SI Joint Fusion From The SI-BONE April 6, 2017 Johnson & Johnson Employee Pleads With CEO, Lawmakers to Help Save DACA January 11, 2018
SI-BONE Announces Published Guidance Recommendation For Minimally Invasive SI Joint Fusion From The SI-BONE April 6, 2017
